BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Aziyo Biologics Announces Second Quarter 2022 Financial Results and Recent Business Achievements, Including Robust Revenue Growth and Strengthened Balance Sheet

  Aziyo Biologics, Inc., a commercial-stage regenerative medicine company, provided a business update and reported financial results for the second quarter June 30, 2022.

  August 11, 2022

   · 

  11 min read
• Biotech Beach

  AVITA Medical Announces Topline Results from Pivotal Trial in Patients with Soft-Tissue Injuries using the RECELL® System

  AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), today announced topline results from its pivotal randomized, controlled trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin harvesting in soft tissue reconstruction.

  August 11, 2022

   · 

  7 min read
• Business

  Tarsus Reports Second Quarter 2022 Financial Results and Recent Business Achievements

  Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for eye diseases, announced financial results for the second quarter ended June 30, 2022, and recent business achievements.

  August 11, 2022

   · 

  10 min read